Table 1 Demographic and laboratory data of stroke patients and control subjects.

Sex (M/F)

5/5

4/4

n.s.

Age yrs. (mean ± SD)

70 ± 13

70 ± 12

n.s.

NIHSS score (median ± SD; range)

22 ± 10; 3-29

-

-

Fugl-Meyer Scale-arm score (median ± SD; range)

11.50 ± 9; 8-44

-

-

CT ischemic area Volume (mL; mean ± SD)

76.10 ± 43.46

-

-

Body Mass Index (mean ± SD)

25.20 ± 2.74

24.63 ± 2.39

n.s.

Cholesterol (mmol/L - mean ± SD)

11.69 ± 2.31

11.64 ± 2.04

n.s.

Triglycerides (mmol/L - mean ± SD)

6.97 ± 2.33

6.82 ± 1.00

n.s.

Blood Glucose (mmol/L - mean ± SD)

5.61 ± 0.71

5.77 ± 0.74

n.s.

AEA T0 (pmol/lipid mg - mean ± SD)

3.42 ± 2.71

1.81 ± 1.53

0.026

AEA T1 (pmol/lipid mg - mean ± SD)

2.87 ± 2.34

-

n.s.

AEA T2 (pmol/lipid mg - mean ± SD)

3.11 ± 2.72

-

n.s.

PEA TO (pmol/lipid mg - mean ± SD)

2.47 ± 0.96

2.05 ± 0.31

n.s.

PEA T1 (pmol/lipid mg - mean ± SD)

2.28 ± 1.01

-

n.s.

PEA T2 (pmol/lipid mg - mean ± SD)

2.17 ± 0.67

-

n.s.

2-AG T0 (pmol/lipid mg - mean ± SD)

3.42 ± 7.22

6.80 ± 9.50

n.s.

2-AG T1 (pmol/lipid mg - mean ± SD)

4.65 ± 4.98

-

n.s.

2-AG T2 (pmol/lipid mg - mean ± SD)

3.29 ± 3.10

-

n.s.